Atea director buys 6,100 shares at $4.17
Atea Pharmaceuticals director Polly A. Murphy reported an open-market purchase of 6,100 shares of Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Atea Pharmaceuticals director Polly A. Murphy reported an open-market purchase of 6,100 shares of Common Stock. The shares were bought on May 18, 2025 at a weighted average price of $4.1715 per share, with individual trade prices ranging from $4.14 to $4.19 per share. Following this transaction, Murphy directly holds 92,145 shares of Atea Pharmaceuticals common stock.
Insider Trade Summary
Net Buyer: 6,100 shares
Net Buy
1 txn
Insider
Murphy Polly A.
Role
Director
Bought
6,100 shs ($25K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 6,100 | $4.1715 | $25K |
Holdings After Transaction:
Common Stock — 92,145 shares (Direct)
Footnotes (1)
- F1. The price reported in Column 4 is a weighted average price. The securities were purchased in multiple transactions at prices ranging from $4.14 to $4.19 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Key Figures
Shares purchased: 6,100 shares
Weighted average price: $4.1715 per share
Trade price range: $4.14–$4.19 per share
+2 more
5 metrics
Shares purchased
6,100 shares
Open-market buy of Common Stock on May 18, 2025
Weighted average price
$4.1715 per share
Average purchase price for 6,100 shares
Trade price range
$4.14–$4.19 per share
Range of individual execution prices on transaction date
Shares owned after transaction
92,145 shares
Direct holdings following the reported purchase
Net buy direction
6,100 net shares bought
transactionSummary shows net-buy activity
Key Terms
open-market purchase, weighted average price, Common Stock, Form 4
4 terms
open-market purchase financial
"transaction_action: "open-market purchase""
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Common Stock financial
"security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Form 4 regulatory
"This purchase was reported on a Form 4"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Atea Pharmaceuticals (AVIR) director Polly A. Murphy do in this Form 4?
Director Polly A. Murphy bought 6,100 shares of Atea Pharmaceuticals Common Stock in an open-market transaction. This purchase was reported on a Form 4 and reflects a personal increase in her direct equity position in the company.
Was Polly A. Murphy’s Atea (AVIR) transaction an open-market purchase?
Yes, the Form 4 characterizes the transaction as an open-market purchase of Common Stock. This is indicated by transaction code “P” and the description “Purchase in open market or private transaction,” confirming it as a straightforward buy in the market.
Does the Form 4 for Atea (AVIR) mention how trade prices were calculated?
The filing explains that the reported $4.1715 figure is a weighted average price. Shares were purchased in multiple transactions between $4.14 and $4.19, and the reporting person offers to provide detailed trade-by-trade pricing information upon request.
AI-generated analysis. How Rhea-AI works. Not financial advice.
